These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38783217)

  • 1. Validation and optimal cut-off score of the World Health Organization Well-being Index (WHO-5) as a screening tool for depression among patients with schizophrenia.
    Fekih-Romdhane F; Al Mouzakzak F; Abilmona G; Dahdouh O; Hallit S
    BMC Psychiatry; 2024 May; 24(1):391. PubMed ID: 38783217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia.
    Bressan RA; Chaves AC; Shirakawa I; de Mari J
    Schizophr Res; 1998 Jun; 32(1):41-9. PubMed ID: 9690333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression Scale.
    Lançon C; Auquier P; Reine G; Toumi M; Addington D
    Psychiatry Res; 1999 Dec; 89(2):123-32. PubMed ID: 10646831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.
    Sarró S; Dueñas RM; Ramírez N; Arranz B; Martínez R; Sánchez JM; González JM; Saló L; Miralles L; San L
    Schizophr Res; 2004 Jun; 68(2-3):349-56. PubMed ID: 15099616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the psychometric properties of the Calgary Depression Scale for Schizophrenics (CDSS) in a Hungarian clinical population of patients with schizophrenia].
    Nagy J; Bitter I
    Neuropsychopharmacol Hung; 2011 Mar; 13(1):33-40. PubMed ID: 21451190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).
    Rostami R; Kazemi R; Khodaie-Ardakani MR; Sohrabi L; Ghiasi S; Sadat Kamali Z; Zaryabi A; Ghiasi Z; Nasiri Z; Rezaei M; Addington DE
    Asian J Psychiatr; 2019 Oct; 45():44-49. PubMed ID: 31493624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's disease.
    Schneider CB; Pilhatsch M; Rifati M; Jost WH; Wodarz F; Ebersbach G; Djundja D; Fuchs G; Gies A; Odin P; Reifschneider G; Wolz M; Bottesi A; Bauer M; Reichmann H; Storch A
    Mov Disord; 2010 Apr; 25(6):777-83. PubMed ID: 20108365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia.
    Hani Y; Ghuloum S; Mahfoud Z; Opler M; Khan A; Yehya A; Abdulhakam A; Hammoudeh S; Al-Mujalli A; Elsherbiny R; Al-Amin H
    PLoS One; 2016; 11(9):e0162304. PubMed ID: 27583831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of the Thai version of the WHO-Five Well-Being Index in primary care patients.
    Saipanish R; Lotrakul M; Sumrithe S
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):141-6. PubMed ID: 19335382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.
    Müller MJ; Brening H; Gensch C; Klinga J; Kienzle B; Müller KM
    J Affect Disord; 2005 Sep; 88(1):69-74. PubMed ID: 16040126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scales for evaluating depressive symptoms in Chinese patients with schizophrenia.
    Liu H; Zhang H; Xiao W; Liu Q; Fu P; Chen J; Wang G; Yang F; Wang G; Wang X; Li L
    J Nerv Ment Dis; 2009 Feb; 197(2):140-2. PubMed ID: 19214051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric evaluation of the Arabic language version of the Birchwood Insight Scale in patients with schizophrenia.
    Fekih-Romdhane F; Bitar Z; Al Mouzakzak F; Abilmona G; Dahdouh O; Hallit S
    BMC Psychiatry; 2024 Mar; 24(1):233. PubMed ID: 38539115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Short Form Depression Screening Questionnaire for Korean Soldiers.
    Byeon G; Jo SJ; Lee HW; Yim HW; Park JI
    J Korean Med Sci; 2021 Jul; 36(27):e185. PubMed ID: 34254472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis.
    Rekhi G; Ng WY; Lee J
    Schizophr Res; 2018 Mar; 193():423-427. PubMed ID: 28712967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Zung self-rating depression scale (SDS) in older adults.
    Jokelainen J; Timonen M; Keinänen-Kiukaanniemi S; Härkönen P; Jurvelin H; Suija K
    Scand J Prim Health Care; 2019 Sep; 37(3):353-357. PubMed ID: 31286810
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sexual dysfunction and depression: Validity of a French version of the ASEX scale].
    Briki M; Haffen E; Monnin J; Tio G; Nicolier M; Sechter D; Vandel P
    Encephale; 2014 Apr; 40(2):114-22. PubMed ID: 23827140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an Arabic version of the GHQ-28 against the Beck depression inventory for screening for depression in war-exposed civilians.
    Farhood LF; Dimassi H
    Psychol Rep; 2015 Apr; 116(2):470-84. PubMed ID: 25826434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients.
    Bernard D; Lançon C; Auquier P; Reine G; Addington D
    Acta Psychiatr Scand; 1998 Jan; 97(1):36-41. PubMed ID: 9504701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Validity and Reliability Study of the Japanese Version of the Geriatric Depression Scale 15 (GDS-15-J).
    Sugishita K; Sugishita M; Hemmi I; Asada T; Tanigawa T
    Clin Gerontol; 2017; 40(4):233-240. PubMed ID: 28452641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Psychometric Properties and the Factor Structure of the Calgary Depression Scale for Schizophrenia Across the Schizotypy Continuum.
    Monsonet M; Kwapil TR; Barrantes-Vidal N
    Assessment; 2022 Jun; 29(4):686-699. PubMed ID: 33522263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.